The anti-inflammatory function of high-density lipoprotein in type II diabetes: A systematic review

作者: Roosmarijn F.H. Lemmers , Mandy van Hoek , Aloysius G. Lieverse , Adrie J.M. Verhoeven , Eric J.G. Sijbrands

DOI: 10.1016/J.JACL.2017.03.013

关键词:

摘要: Background Inflammation is a pathophysiological factor in diabetes and its cardiovascular complications. High-density lipoprotein (HDL) suppresses inflammation healthy individuals. The relationship of HDL with disease may be explained by function rather than cholesterol level. In diabetes, seems to become dysfunctional. Objective We performed systematic review answer the following research questions: Is anti-inflammatory diminished individuals if so, what causes this? Methods systematically searched Medline Embase included original articles on effects or HDL-based interventions models. assessed risk bias all studies. Results Fourteen studies were included. These showed great heterogeneity methodology, study populations, Overall, from subjects type II displayed reduced ability suppress inflammatory processes markers. However, mechanisms in vivo remain largely unknown. No reported other types diabetes. most studies, was high could not assessed. Conclusions isolated decreased inflammation. direction causality underlying are unknown should investigated. For development treatments directed at restoring standardized method for assessing needs developed biomarkers must identified.

参考文章(71)
Anatol Kontush, M. John Chapman, High-Density Lipoproteins: Structure, Metabolism, Function, and Therapeutics John Wiley & Sons, Inc.. ,(2011) , 10.1002/9781118158678
Julian P. T. Higgins, Sally Green, Cochrane Handbook for Systematic Reviews of Interventions ,(2019)
Nathalie M. Delzenne, Patrice D. Cani, Amandine Everard, Audrey M. Neyrinck, Laure B. Bindels, Gut Microorganisms as Promising Targets for the Management of Type 2 Diabetes Diabetologia. ,vol. 58, pp. 2206- 2217 ,(2015) , 10.1007/S00125-015-3712-7
Marcus D. Säemann, Marko Poglitsch, Chantal Kopecky, Michael Haidinger, Walter H. Hörl, Thomas Weichhart, The versatility of HDL: a crucial anti-inflammatory regulator European Journal of Clinical Investigation. ,vol. 40, pp. 1131- 1143 ,(2010) , 10.1111/J.1365-2362.2010.02361.X
Anatol Kontush, HDL particle number and size as predictors of cardiovascular disease. Frontiers in Pharmacology. ,vol. 6, pp. 218- 218 ,(2015) , 10.3389/FPHAR.2015.00218
Donghui Liu, Liang Ji, Dongmei Zhang, Xunliang Tong, Bing Pan, Pinli Liu, Youyi Zhang, Yining Huang, Jinzi Su, Belinda Willard, Lemin Zheng, Nonenzymatic glycation of high-density lipoprotein impairs its anti-inflammatory effects in innate immunity. Diabetes-metabolism Research and Reviews. ,vol. 28, pp. 186- 195 ,(2012) , 10.1002/DMRR.1297
Scott M. Gordon, Susanna Hofmann, David S. Askew, W. Sean Davidson, High density lipoprotein: it's not just about lipid transport anymore Trends in Endocrinology & Metabolism. ,vol. 22, pp. 9- 15 ,(2011) , 10.1016/J.TEM.2010.10.001
C. Roger White, David W. Garber, G. M. Anantharamaiah, Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: a review Journal of Lipid Research. ,vol. 55, pp. 2007- 2021 ,(2014) , 10.1194/JLR.R051367
A. Hoang, A. J. Murphy, M. T. Coughlan, M. C. Thomas, J. M. Forbes, R. O’Brien, M. E. Cooper, J. P. F. Chin-Dusting, D. Sviridov, Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties Diabetologia. ,vol. 50, pp. 1770- 1779 ,(2007) , 10.1007/S00125-007-0718-9